SYSTEMATIC INVESTIGATION OF DENTAL, HEART AND LUNG DISEASES IN PATIENTS WITH COVID-19 AND HOSPITALIZED IN ICU BASED ON RADIOLOGY STEREOTYPES

In this study, dental, heart and lung diseases in patients with Covid-11 and hospitalized in ICU have been investigated based on radiology stereotypes. During the past months, it has been determined that the risk of this disease is greater for some people who have heart and lung diseases or suffer from complications such as high blood pressure and diabetes, and it is necessary for this group of people to be more careful. lack of contact with sick people, so that many of these people, who were under regular medical care before the corona disease, refuse to see a doctor due to the fear of being in environments infected with the corona virus, such as offices and clinics and naturally, the amount of previous care and sensitivities has been reduced, an issue that can be seen even in people without primary disease and with the onset of the first disease. During the past months, it has been abundantly observed that people with symptoms of heart attacks and heart failure have refused to go to the medical center and emergency system due to the fear of medical centers, and unfortunately, this issue causes delays in treatment and sometimes even irreversible complications. It has been compensated. People who have a history of heart disease and regularly use drugs should communicate with their doctor about the effectiveness of the drugs, their side effects and the need to change the drugs on a regular basis. Not going to the doctor does not mean disconnection from the treatment system and this can lead to many complications. People with heart disease or high blood pressure happen to be more at risk of complications from corona disease than other people, and if they are infected, their symptoms are more severe and the possibility of complications of the disease is more in them than others. Therefore, it is necessary for these people to use medical advice as soon as symptoms related to the disease appear. Denial of the disease and fear of going to the medical center can delay the diagnosis and the subsequent complications of the disease. [ABSTRACT FROM AUTHOR] Copyright of Journal of Pharmaceutical Negative Results is the property of ResearchTrentz and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Comparison of the prevalence of opioid use among U.S. adults with cardiac conditions before and during the COVID-19 pandemic.

Limited data are available on the prevalence of prescription opioid use among patients with cardiac conditions who were exposed to increased risks of cardiac events including myocardial failure and cardiac arrest. According to the U.S. National Health Interview Survey, we evaluated the prevalence of opioid use in patients with cardiac conditions who reported prescription opioid use in the past 12 months and 3 months in 2019 and 2020, respectively, and further estimated the prevalence of opioid use for acute pain or chronic pain. We also analyzed the stratified prevalence by demographical characteristics. Our results showed that there was no statistically significant change in the prevalence of opioid use in the past 12 months (26.5% in 2019 vs. 25.7% in 2020) or the past 3 months (66.6% in 2019 vs. 62.5% in 2020) before and during the COVID-19 pandemic. However, there was a significant decline in the prevalence of opioid use for acute pain, from 64.2% (95% confidence interval [CI] 57.6% to 70.3%) in 2019 to 49.6% (95% CI 40.1% to 59.0%) in 2020 (P = 0.012), particularly in the subgroups of men, non-Hispanic white people, adults with education below high school, those with an income-to-poverty ratio ranging from 1.0 to 1.9, and those covered with health insurance. Our findings suggest that monitoring opioid use in the era of living with COVID-19 is important, which will help inform healthcare providers to develop care strategies to reduce health loss for vulnerable individuals.

Management of Cardiac Patients in Epidemic Outbreak.

In times of COVID-19 epidemic/pandemic, cardiac patients are vulnerable group with many specific conditions that could aggravate their condition. In this narrative review, we present possible measures adequate in managing cardiac patients in epidemic outbreak. An overview of the role of cardiologists and Crisis Management Team in management of cardiac patients is given. Protocols and measures implemented in COVID-19 crises are presented in light of risk assessment and disease prevention of cardiac patients and measures that should be taken for each cardiac condition. Specificity of epidemics calls for specific measures in addressing cardiac patients as part of the affected population. Many possible outcomes could be expected in an epidemic outbreak in relation to cardiovascular diseases, but tailored measures will keep cardiac patients safe. Proposed preventive measures for cardiac patients could be implemented in existing protocols for epidemic outbreak.

Сравнительный анализ данных амбулаторных электронных медицинских карт пациентов с хронической сердечной недостаточностью разных возрастов: результаты и проблемы

Цель. Определить клинические особенности и тактику ведения пациентов с хронической сердечной недостаточностью (ХСН) трех возрастных групп на основании анализа электронных медицинских карт (ЭМК). Материал и методы. Проанализированы 683 ЭМК пациентов из медицинских учреждений городских округов Московской области, обратившихся за медицинской помощью в 2021 г, у которых в качестве одного из кодов диагноза (осложнений) был указан код I50 (сердечная недостаточность). Для анализа сформированы 3 возрастные группы пациентов: 18-59 лет;60-70 лет;старше 71 года. Результаты. Выявлены статистически значимые различия в частоте регистрации артериальной гипертензии (85;90 и 94% соответственно), кардиомиопатии (5,6;0,8 и 0,4%), перенесенного COVID-19 (78;26 и 17%), госпитализаций по любой причине (52;43 и 63%). При этом различий в частоте госпитализаций с диагнозом COVID-19 не выявлено (4,4;4,5 и 4,6% соответственно). Доля женщин в выборке значимо увеличивалась с возрастом (32;49 и 65%)...

Primary care cardiovascular disease prevention post-pandemic: a call to action

Optimisation of hypertension identification and treatment is key to reducing health inequalities. Kate Phillips and Luke Evans highlight the role practice nurses can play in implementing the national Blood Pressure Optimisation Programme

Caution against the new normal

The article reports on the need to improve plans for care of patients with cardiovascular disease even after the COVID-19 pandemic in Great Britain.

The Effect of Correct Handwashing and Mask Wearing Training on Cardiac Patients' COVID-19 Fear and Anxiety.

PURPOSE: This study was conducted to determine the effect of correct handwashing and mask-wearing training on COVID-19 fear and generalized anxiety in cardiac patients. METHODS: Randomized controlled experimental study with the formation of intervention and control groups. DESIGN: The study (triple-blind) was conducted between August 11 and November 17, 2020, in the cardiology clinic of a tertiary hospital in western Turkey. The pre-study sample size was calculated as a minimum 45 at 80% strength, 0.05 significance level, and 0.60 influence quantity for each group. 112 volunteers meeting the criteria were included in the study. The study was completed with a total of 105 individuals in the intervention group (n=50) and control group (n=53). The post-study strength was (1- ß) =1. This study was performed in five stages: (1) collection of data, (2) randomization, (3) providing training, (4) contacting the intervention and control groups for follow-up a month later, and (5) collection of the follow-up data. FINDINGS: The training provided to cardiac patients increased the correct handwashing technique (U=36.00; p<0.001) and the correct mask-wearing technique (U=99.00; p<0.001) and decreased COVID-19 fear (U=883.5; p<0.001) and anxiety (U=751.0; p<0.001) (p <.05). CONCLUSION: It can be considered that the training provided to the cardiac patients in preventing COVID-19 may also be suitable for other risk groups. CLINICAL EVIDENCE: Practical training at the individual level can be used to train cardiac patients.

Artificial Intelligence-Based Phonocardiogram: Classification Using Cepstral Features

When cardiovascular issues arise in a cardiac patient, it is essential to diagnose them as soon as possible for monitoring and treatment would be less difficult than in the old. Paediatric cardiologists have a difficult time keeping track of their patients’ cardiovascular condition. To accomplish this, a phonocardiogram (PCG) device was created in combination with a MATLAB software based on artificial intelligence (AI) for automatic diagnosis of heart state classification as normal or pathological. Due to the safety concerns associated with COVID-19, testing on school-aged children is currently being explored. Using PCG analyses and machine learning methods, the goal of this work is to detect a cardiac condition, whilst operating on a limited amount of computing resources. This makes it possible for anybody, including non-medical professionals, to diagnose cardiac issues. To put it simply, the current system consists of a distinct portable electronic stethoscope, headphones linked to the stethoscope, a sound-processing computer, and specifically developed software for capturing and analysing heart sounds. However, this is more difficult and time-consuming, and the accuracy is lowered as a result. According to statistical studies, even expert cardiologists only achieve an accuracy of approximately 80%. Nevertheless, primary care doctors and medical students usually attain a level of accuracy of between 20 and 40%. Due to the nonstationary nature of heart sounds and PCG's superior ability to model and analyse even in the face of noise, PCG sounds provide valuable information regarding heart diseases. Spectral characteristics PCG is used to characterise heart sounds in order to diagnose cardiac conditions. We categorise normal and abnormal sounds using cepstral coefficients, or PCG waves, for fast and effective identification, prompted by cepstral features’ effectiveness in speech signal classification. On the basis of their statistical properties, we suggest a new feature set for cepstral coefficients. The PhysioNet PCG training dataset is used in the experiments. This section compares KNN with SVM classifiers, indicating that KNN is more accurate. Furthermore, the results indicate that statistical features derived from PCG Mel-frequency cepstral coefficients outperform both frequently used wavelet-based features and conventional cepstral coefficients, including MFCCs. © 2022, The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

Questions Individuals with Cardiac Conditions Engaging in Exercise often Ask Health Fitness Professionals: Research-Based Responses

By reading this article, the health and fitness professional will learn empiric and research-based responses and answers to common questions individuals with cardiac conditions often pose. These practical data, and the authors' shared clinical experiences in fielding these questions over the years, should be helpful to the health and fitness professional when working with the escalating population of clients with known cardiovascular disease who are seeking safe and effective exercise regimens to enhance cardiovascular health, functional independence, and well-being.

EARLY RESPIRATORY OUTCOMES FOLLOWING CARDIAC SURGERY IN PATIENTS WITH COVID-19

Four patients underwent off-pump cardiac surgery and 21 underwent on-pump cardiac surgery with a median cardiopulmonary bypass time of 85 minutes (interquartile range (IQR, 50-147). B Conclusions: b Although early respiratory outcomes of asymptomatic COVID-19 patients who underwent early cardiac surgery appeared to be satisfactory, compared to the propensity-scored matched non-COVID group, the postoperative outcomes were worse, especially in the ICU readmitted patients. [Extracted from the article] Copyright of Critical Care Medicine is the property of Lippincott Williams & Wilkins and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)

Major cardiac concerns in therapy and vaccinations for COVID-19.

The necessity and impact of SARS-CoV-2 on the world's health have led to the development and production of practical and useful vaccines for this deadly respiratory virus. Since April 2020, a vaccine for the virus has been developed. Given that comorbidities such as diabetes, hypertension, and cardiovascular disease are more prone to viruses and the risk of infection, vaccines should be designed to protect against high-risk respiratory illnesses. In this review, we discussed the cardiovascular alteration in SARS-CoV-2 treatment, and we also reviewed the vaccination information and studies that have been done to primary considerations for cardiac patients.